. Author manuscript; available in PMC: 2017 Oct 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2016 May 20;14(10):1376–1384. doi: 10.1016/j.cgh.2016.05.022

Table 2.

Summary of the Sendai Consensus Guidelines (SCG) and International Consensus Guidelines (ICG) for Selecting Patients with Pancreatic Cysts for Surgical Resection (refs. 19,20)

Guideline	Criteria
SENDAI Consensus Guidelines
MD-IPMN	MPD ≥10mm
SCG +ve BD-IPMN	Size >3cm
SCG +ve BD-IPMN	Size ≤3cm with symptoms/mural nodules/MPD dilation (>6mm)/+ve cytology
International Consensus Guidelines
High risk features	Proximal lesion with obstructive jaundice
	Enhancing nodules
	Dilated main duct (≥10mm)
Worrisome risk features	Size ≥3cm
	Pancreatitis
	Non-enhancing nodules
	Thickened, enhancing walls
	Dilated duct (5 to <10mm)
	Change in duct caliber with distal atrophy
	Lymphadenopathy

MPD: Main pancreatic duct; MD-IPMN: Main-duct intraductal papillary mucinous neoplasm; BD-IPMN: Branch-duct intraductal papillary mucinous neoplasm.